Response to Comments: Pharmacogenomics Testing

This file (A58922) is a response-to-comments document for Proposed LCD DL39073 on pharmacogenomics testing and does not itself state coverage criteria. Review the final LCD DL39073 for specific indications, limitations, documentation requirements, and frequency limits; manual review of the final LCD is required to extract actionable coverage criteria.

"This document summarizes public comments and contractor responses related to Proposed LCD DL39073 (Pharmacogenomics Testing); the final LCD DL39073 contains the applicable coverage criteria and req..."

Sign up to see full coverage criteria, indications, and limitations.